Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 156 of the 159 references it cites were found in a registry or an index.

Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson’s Disease

Open access
Sancandi, Marco, Uysal-Onganer, Pinar, Kraev, Igor, Mercer, Audrey, Lange, Sigrun · 2020 · International Journal of Molecular Sciences

Abstract

The identification of biomarkers for early diagnosis of Parkinson’s disease (PD) is of pivotal importance for improving approaches for clinical intervention. The use of translatable animal models of pre-motor PD therefore offers optimal opportunities for novel biomarker discovery in vivo. Peptidylarginine deiminases (PADs) are a family of calcium-activated enzymes that contribute to protein misfolding through post-translational deimination of arginine to citrulline. Furthermore, PADs are an active regulator of extracellular vesicle (EV) release. Both protein deimination and extracellular vesicles (EVs) are gaining increased attention in relation to neurodegenerative diseases, including in PD, while roles in pre-motor PD have yet to be investigated. The current study aimed at identifying protein candidates of deimination in plasma and plasma-EVs in a rat model of pre-motor PD, to assess putative contributions of such post-translational changes in the early stages of disease. EV-cargo was further assessed for deiminated proteins as well as three key micro-RNAs known to contribute to inflammation and hypoxia (miR21, miR155, and miR210) and also associated with PD. Overall, there was a significant increase in circulating plasma EVs in the PD model compared with sham animals and inflammatory and hypoxia related microRNAs were significantly increased in plasma-EVs of the pre-motor PD model. A significantly higher number of protein candidates were deiminated in the pre-motor PD model plasma and plasma-EVs, compared with those in the sham animals. KEGG (Kyoto encyclopedia of genes and genomes) pathways identified for deiminated proteins in the pre-motor PD model were linked to “Alzheimer’s disease”, “PD”, “Huntington’s disease”, “prion diseases”, as well as for “oxidative phosphorylation”, “thermogenesis”, “metabolic pathways”, “Staphylococcus aureus infection”, gap junction, “platelet activation”, “apelin signalling”, “retrograde endocannabinoid signalling”, “systemic lupus erythematosus”, and “non-alcoholic fatty liver disease”. Furthermore, PD brains showed significantly increased staining for total deiminated proteins in the brain vasculature in cortex and hippocampus, as well as increased immunodetection of deiminated histone H3 in dentate gyrus and cortex. Our findings identify EVs and post-translational protein deimination as novel biomarkers in early pre-motor stages of PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21082743

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Plasma-extracellular vesicles (EVs) are elevated in pre-motor Parkinson’s disease (PD) model rats. (A) The number of circulating plasma-EVs was significantly increased in plasma of the pre-motor PD model rats, compared with that in plasma of sham control rats (p < 0.05; unpaired t-test). (B) Modal size of plasma-EVs did not differ between plasma from the pre-motor PD rat model compared to control shams. Exact p-values are indicated (n = 3 biological replicates for all; ctrl = sham; PD = pre-motor PD models).
Figure 1 Plasma-extracellular vesicles (EVs) are elevated in pre-motor Parkinson’s disease (PD) model rats. (A) The number of circulating plasma-EVs was significantly increased in plasma of the pre-motor PD model rats, compared with that in plasma of sham control rats (p < 0.05; unpaired t-test). (B) Modal size of plasma-EVs did not differ between plasma from the pre-motor PD rat model compared to control shams. Exact p-values are indicated (n = 3 biological replicates for all; ctrl = sham; PD = pre-motor PD models).CC BY · PubMed Central
Figure 2 EV characterisation from rat plasma. (A) Representative Nanosight graphs showing nanoparticle tracking analysis (NTA) analysis of plasma EV profiles from sham-treated rats (Sham; n = 3). (B) Representative Nanosight graphs showing NTA analysis of plasma EV profiles from the pre-motor PD rat models (PD; n = 3). (C) Western blotting (WB) confirms that rat plasma-EVs are positive for the EV-specific markers CD63 and flotillin-1 (Flot-1); the molecular weight standard is indicated in kilo Daltons (kDa). (D,E) Transmission electron microscopy (TEM) images showing EVs isolated from sham (D) and pre-motor PD model (PD; (E)) rat plasma, revealing typical EV morphology; composite images are shown and the scale bar represents 50 nm in all images. In the NTA curves the black line represents the mean of the 5 repetitive readings per individual sample and the red line represents standard error (+/−) between those same 5 readings per sample. Each treatment group was measured in 3 biological replicates (sham; PD = pre-motor PD models).
Figure 2 EV characterisation from rat plasma. (A) Representative Nanosight graphs showing nanoparticle tracking analysis (NTA) analysis of plasma EV profiles from sham-treated rats (Sham; n = 3). (B) Representative Nanosight graphs showing NTA analysis of plasma EV profiles from the pre-motor PD rat models (PD; n = 3). (C) Western blotting (WB) confirms that rat plasma-EVs are positive for the EV-specific markers CD63 and flotillin-1 (Flot-1); the molecular weight standard is indicated in kilo Daltons (kDa). (D,E) Transmission electron microscopy (TEM) images showing EVs isolated from sham (D) and pre-motor PD model (PD; (E)) rat plasma, revealing typical EV morphology; composite images are shown and the scale bar represents 50 nm in all images. In the NTA curves the black line represents the mean of the 5 repetitive readings per individual sample and the red line represents standard error (+/−) between those same 5 readings per sample. Each treatment group was measured in 3 biological replicates (sham; PD = pre-motor PD models).CC BY · PubMed Central
Figure 3 MicroRNA analysis of inflammatory and hypoxia associated microRNAs in circulating plasma-EVs of pre-motor PD and sham animals. (A) Significantly increased relative expression of the inflammatory miR21 was observed in plasma-EVs of the pre-motor PD rats, compared with shams. (B) Significantly increased relative expression of the inflammatory miR155 was observed in plasma-EVs of pre-motor PD rats, compared with shams. (C) The relative expression of the hypoxia related miR210 was significantly increased in plasma-EVs of pre-motor PD rats, compared with those of sham-treated animals. Results are represented as relative microRNA (miR) expression compared to the internal control miRs (2Λ(-DDCT)); exact p-values are indicated, error bars show SD (n = 3 biological and three technical replicates for all; ctrl = sham; PD = pre-motor PD models).
Figure 3 MicroRNA analysis of inflammatory and hypoxia associated microRNAs in circulating plasma-EVs of pre-motor PD and sham animals. (A) Significantly increased relative expression of the inflammatory miR21 was observed in plasma-EVs of the pre-motor PD rats, compared with shams. (B) Significantly increased relative expression of the inflammatory miR155 was observed in plasma-EVs of pre-motor PD rats, compared with shams. (C) The relative expression of the hypoxia related miR210 was significantly increased in plasma-EVs of pre-motor PD rats, compared with those of sham-treated animals. Results are represented as relative microRNA (miR) expression compared to the internal control miRs (2Λ(-DDCT)); exact p-values are indicated, error bars show SD (n = 3 biological and three technical replicates for all; ctrl = sham; PD = pre-motor PD models).CC BY · PubMed Central
Figure 4 F95-enriched fractions from plasma and plasma-EVs from pre-motor PD model and sham rats. Silver stained sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel (4–20% gradient gel), showing F95-enriched protein bands from whole plasma and plasma-EVs in pre-motor PD and sham (control) rats. The protein standard is indicated on the far left in kilodaltons (kDa) (ctrl = sham; PD = pre-motor PD models).
Figure 4 F95-enriched fractions from plasma and plasma-EVs from pre-motor PD model and sham rats. Silver stained sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel (4–20% gradient gel), showing F95-enriched protein bands from whole plasma and plasma-EVs in pre-motor PD and sham (control) rats. The protein standard is indicated on the far left in kilodaltons (kDa) (ctrl = sham; PD = pre-motor PD models).CC BY · PubMed Central
Figure 5 Venn diagram showing deiminated protein hits identified in plasma and plasma-EVs of pre-motor PD model and of sham rats. (A) A considerable higher number of deiminated protein hits was identified in plasma of the pre-motor PD model rats, compared with that in shams, with some overlapping protein hits. (B) A higher number of protein hits was identified to be deiminated in circulating plasma-EVs of the pre-motor PD rat models, compared with that in shams, with some hits overlapping.
Figure 5 Venn diagram showing deiminated protein hits identified in plasma and plasma-EVs of pre-motor PD model and of sham rats. (A) A considerable higher number of deiminated protein hits was identified in plasma of the pre-motor PD model rats, compared with that in shams, with some overlapping protein hits. (B) A higher number of protein hits was identified to be deiminated in circulating plasma-EVs of the pre-motor PD rat models, compared with that in shams, with some hits overlapping.CC BY · PubMed Central
Figure 6 Kyoto encyclopedia of genes and genomes (KEGG) pathways for deiminated proteins identified in plasma of sham and pre-motor PD model rats. (A) KEGG pathways identified in circulating EVs of sham-treated (control) rat plasma are highlighted. Colour codes for nodes included in the figure. (B) KEGG pathways identified for deiminated proteins in circulating EVs of pre-motor PD model rat plasma are highlighted; notably pathways for PD and other neurodegenerative disease are identified for deiminated proteins in the pre-motor PD plasma-EVs. See colour codes for nodes and for connecting lines in the figure.
Figure 6 Kyoto encyclopedia of genes and genomes (KEGG) pathways for deiminated proteins identified in plasma of sham and pre-motor PD model rats. (A) KEGG pathways identified in circulating EVs of sham-treated (control) rat plasma are highlighted. Colour codes for nodes included in the figure. (B) KEGG pathways identified for deiminated proteins in circulating EVs of pre-motor PD model rat plasma are highlighted; notably pathways for PD and other neurodegenerative disease are identified for deiminated proteins in the pre-motor PD plasma-EVs. See colour codes for nodes and for connecting lines in the figure.CC BY · PubMed Central
Figure 7 KEGG pathways for deiminated proteins in plasma-EVs of sham and pre-motor PD model rats. (A) KEGG pathways identified in circulating plasma-EVs of sham (control) rats are highlighted. See colour code for nodes included in the figure. (B) KEGG pathways identified for deiminated proteins in circulating plasma-EVs of the pre-motor PD model rats are highlighted. See colour codes for nodes and connecting lines in the figure.
Figure 7 KEGG pathways for deiminated proteins in plasma-EVs of sham and pre-motor PD model rats. (A) KEGG pathways identified in circulating plasma-EVs of sham (control) rats are highlighted. See colour code for nodes included in the figure. (B) KEGG pathways identified for deiminated proteins in circulating plasma-EVs of the pre-motor PD model rats are highlighted. See colour codes for nodes and connecting lines in the figure.CC BY · PubMed Central
Figure 8 Total deiminated proteins are increased in brain tissue of pre-motor PD rats. Total deiminated protein expression was assessed by immunohistochemistry using the pan-deimination F95 antibody. (A) Increased protein deimination is observed in the brain vasculature in the cortex (ctx) of the pre-motor PD rat brains compared with that in the sham control brains. (B) Increased protein deimination is observed in white matter (wm) of the pre-motor PD rat brains compared with sham brains. (C) Increased protein deimination (F95 positive) is observed in the hippocampus (hip) of the pre-motor PD rat brains, compared with sham brains; the scale bars indicate 100 µm in all figures (ctx = cortex, hip = hippocampus, wm = white matter). (D,E) Thresholding intensity analysis of F95 positive staining showed a significant increase in the cortex (D), and the CA1 region of the hippocampus (E) of pre-motor PD models, compared with that in control sham brains (unpaired t-test, *** p < 0.001).
Figure 8 Total deiminated proteins are increased in brain tissue of pre-motor PD rats. Total deiminated protein expression was assessed by immunohistochemistry using the pan-deimination F95 antibody. (A) Increased protein deimination is observed in the brain vasculature in the cortex (ctx) of the pre-motor PD rat brains compared with that in the sham control brains. (B) Increased protein deimination is observed in white matter (wm) of the pre-motor PD rat brains compared with sham brains. (C) Increased protein deimination (F95 positive) is observed in the hippocampus (hip) of the pre-motor PD rat brains, compared with sham brains; the scale bars indicate 100 µm in all figures (ctx = cortex, hip = hippocampus, wm = white matter). (D,E) Thresholding intensity analysis of F95 positive staining showed a significant increase in the cortex (D), and the CA1 region of the hippocampus (E) of pre-motor PD models, compared with that in control sham brains (unpaired t-test, *** p < 0.001).CC BY · PubMed Central
Figure 9 Deiminated histone H3 staining is increased in the cortex and dentate gyrus of pre-motor PD models. Immunohistochemical staining showed increased protein detection of deiminated histone H3 (citH3) in: (A)) the dentate gyrus; (B) the cortex of the pre-motor PD models, compared with those in the control sham animals. The scale bars indicate 100 µm in all figures.
Figure 9 Deiminated histone H3 staining is increased in the cortex and dentate gyrus of pre-motor PD models. Immunohistochemical staining showed increased protein detection of deiminated histone H3 (citH3) in: (A)) the dentate gyrus; (B) the cortex of the pre-motor PD models, compared with those in the control sham animals. The scale bars indicate 100 µm in all figures.CC BY · PubMed Central
Figure 10 PAD2, PAD3, and PAD4 protein detection in pre-motor PD model and sham brain tissue. (A) PAD2 protein detection in cortex (ctx), white matter (wm) and hippocampus (hip) of sham and pre-motor PD models. (B) PAD3 protein detection in cortex, white matter, and hippocampus of shams and pre-motor PD rats. (C) PAD4 protein detection in cortex, white matter and hippocampus of shams and pre-motor PD rats. The scale bars indicate 100 µm in all figures (ctx = cortex, hip = hippocampus, wm = white matter).
Figure 10 PAD2, PAD3, and PAD4 protein detection in pre-motor PD model and sham brain tissue. (A) PAD2 protein detection in cortex (ctx), white matter (wm) and hippocampus (hip) of sham and pre-motor PD models. (B) PAD3 protein detection in cortex, white matter, and hippocampus of shams and pre-motor PD rats. (C) PAD4 protein detection in cortex, white matter and hippocampus of shams and pre-motor PD rats. The scale bars indicate 100 µm in all figures (ctx = cortex, hip = hippocampus, wm = white matter).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 159 references

Cited by

See all 41

Metadata

Authors
Sancandi, M., Uysal-Onganer, P., Kraev, I., Mercer, A., & Lange, S.
Affiliations
  • UCL School of Pharmacy (GB)
  • Cancer Research Group, School of Life Sciences, University of Westminster, London W1W 6XH, UK
  • The Open University (GB)
  • University of Westminster (GB)
Corresponding author
Lange, Sigrun
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-04-15
Volume
21
Issue
8
Pages
2743
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3017346163
Cited by
41
References
159
Citations by year
2026: 4 · 2025: 6 · 2024: 8 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 5
FWCI
2.27
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Open Research Online - ORO (The Open University) (acceptedVersion)
  • WestminsterResearch (University of Westminster) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • University of Westminster
  • School of Pharmacy, University College London
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Parkinson's disease, peptidylarginine deiminase, protein deimination, extracellular vesicles, plasma biomarkers, cerebral vasculature, microRNA, MIR21, miR-155, oxidative phosphorylation, neuroinflammation, hypoxia
MeSH terms
Extracellular Vesicles, Citrullination, Protein-Arginine Deiminases, Animals, Brain, Chromatography, Liquid, Disease Models, Animal, Immunohistochemistry, Male, Parkinson Disease, Protein Processing, Post-Translational, Biomarkers, Rats, Sprague-Dawley, MicroRNAs, Proteomics, Microscopy, Electron, Transmission, Rats, Tandem Mass Spectrometry, Protein Interaction Maps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson’s Disease. https://app.cochat.ai/papers/10.3390/ijms21082743
The paper
Sancandi, M., Uysal-Onganer, P., Kraev, I., Mercer, A., & Lange, S. (2020). Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21082743

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.